Vyne Therapeutics Inc. (VYNE)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
28. 56
0
0%
After Hours
$
+7.86 +27.5385% 36. 42
19.07M Market Cap
- P/E Ratio
- Div Yield
93,256 Volume
-1 Eps
$ 28.56
Previous Close Want to track VYNE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vyne Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 365.96 | $11,910.17 | $10,193.82 | -$1,716.35 | -14.41% |
 Jeffrey Gundlach DoubleLine Capital LP | 448 | $2.57M | $12,479.04 | -$2.56M | -99.51% |
 Richard Slavik Newbridge Financial Services Group Inc. | 0.2 | $3.35 | $8.5 | $5.15 | 153.73% |
| KJ Ken Joseph Braidwel LLP | 18,321.54 | $547,356.01 | $778,482.23 | $231,126.22 | 42.23% |
 George Song Superstring Capital Management LP | 1,225.38 | $39,867.74 | $52,066.4 | $12,198.66 | 30.6% |
 Paul V. Ryan Jr FLAGSHIP WEALTH ADVISORS, LLC | 0.02 | $0.63 | $0.56 | -$0.07 | -11.11% |
| AH Anders Hove Acorn Capital Advisors LLC | 28.5 | $2,251.5 | $1,210.96 | -$1,040.54 | -46.22% |
| LC Leslie Childs MB Levis & Associates LLC | 20.82 | $3,206.01 | $579.94 | -$2,626.07 | -81.91% |
